Save The Snakes protects snake populations and mitigates human-snake conflict globally. Through grassroots, frontline initiatives, we empower high-burden communities in Africa, Asia, and Latin America with on-the-ground prevention measures and local first-responder training.

We are a women-led health technology company transforming access to emergency care in Kenya. Through a network spanning all 47 counties, over 400 ambulances, 300+ healthcare facilities, and community-based responders, Ambulex delivers timely and affordable emergency response for underserved populations. We work closely with public and private partners to strengthen maternal health outcomes and provide survivor-centered emergency response and referral services for gender-based violence.

Dr. Juliana Zuliani is a senior researcher at Fiocruz Rondônia whose work bridges immunology, toxinology, inflammation, and translational medicine. Based in the Brazilian Amazon, she investigates animal venoms. She conducts a hospital-based clinical trial using red and infrared laser photobiomodulation to reduce local symptoms associated with antivenom serum therapy. Her leadership strengthens Amazonian science and patient-centered innovation.

I am Dr Okpashi Victor Eshu, a senior Lecturer and a researcher in the Department of Biochemistry, University of Cross River State, Nigeria. My research interests ranged widely from Molecular Biochemistry and industrial Biotechnology.

I am the Centre Manager for the Synthetic Biology and Precision Medicine Centre at CSIR South Africa. I established an emerging area on the Synthetic Nanobiotechnology Laboratory at the Synthetic Biology and Precision Medicine Centre. I led and contributed to the South African Synthetic Biology Roadmap (SASB) and Implementation Plan together with members from the DSTI ((https://www.dsti.gov.za/index.php/documents/strategies-and-reports/298-synthetic-biology-roadmap-publication)

Dr. Lucy N. Namusonge is a public health researcher, nurse educator, and implementation scientist with expertise in maternal and child health, community health systems, health promotion, and digital health. She holds qualifications in Nursing, Public Health, and a PhD in Public Health. Her research focuses on health systems strengthening, quality improvement, and community-based interventions. She is committed to developing scalable, evidence-based innovations that improve timely referral

A pharmaceutical and Medicinal Chemistry with an interest in natural product chemistry and drug discovery

I work at the intersection of evidence synthesis and indigenous storytelling, helping communities understand and act on research.

I am the Deputy Executive Director at the Centre for Plant Medicine Research, Mampong-Akuapem in Ghana. I am a pharmacologist and currently working actively with traditional healers in Ghana to validate traditional remedies for the treatment of snakebite envenomation.

Synergya is a venture scaler for health and sustainability founders, built so no founder is left behind by helping them build and scale together. A Swiss social enterprise, Synergya runs zero-fees, zero-equity Joint Venture infrastructure for founders from preseed to Series C. It grew from the work behind HealthTech Hub Africa, the accelerator that scaled across 17 African countries and 68+ startups, reaching ~3 million people and winning the 2023 US Government P3 Impact Award for best PPP.